Beneficiary

The Netherlands Cancer Institute (NKI)

Amsterdam

Netherlands

The Netherlands Cancer Institute (NKI) in Amsterdam is a distinguished entity within the Dutch healthcare system, dedicated to specialized cancer care. NKI stands as a premier national and international reference in oncology for treatment, research, and education. It is accredited as a Comprehensive Cancer Center by the European Organization for Research and Treatment of Cancer (EORTC).

‍

Key People Involved:

Professor Emile Voest

MD, PhD, Director Cancer Core Europe and Professor and Medical Oncologist, The Netherlands Cancer Institute

Floor Verbeek

MD, PhD fellow and DRUP study doctor

Femke Verwer

Clinical Project Manager

partners

Beneficiaries & Associated Partners

Associated Partner

Center for Innovation in Medicine (InoMed)

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Associated Partner

University of Manchester

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Beneficiary

Swedish Institute for Health Economics (IHE)

Work package leader implementation in everyday practice (WP5).